Important Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) at present introduced its 2024 international Request for Proposals for its Breakthrough Analysis and Innovation in Drug Improvement Grants, often known as BRIDGe. These BRIDGe awards are designed to assist tutorial researchers in traversing the drug improvement valley of loss of life by offering funding and defining optimum methods for advancing new, cutting-edge therapeutics from the lab to sufferers.
Maaike Everts, Ph.D., Government Director of C-Path’s TRxA, expressed her enthusiasm for this subsequent cycle of awards, stating, “The impactful progress in our presently funded tasks serves as a testomony to the facility of collaboration in drug discovery and improvement; we stay up for figuring out the distinctive tasks that can emerge from this cycle and, collectively, shaping the subsequent era of life altering medicines.”
As a nonprofit drug accelerator, TRxA offers the next for principal investigators who’re chosen to obtain a BRIDGe award:
- Tactical and strategic drug discovery and improvement experience, together with regulatory science concerns.
- Sources and hands-on steering, working intently with tutorial researchers to develop complete knowledge packages for potential drug candidates, a key to garnering curiosity from biotechnology and pharmaceutical corporations to put money into scientific trials.
- Engagement of contract analysis organizations (CRO) to carry out essential discovery part experiments and/or validate tutorial research.
Extra details about this funding alternative is out there in TRxA’s Steerage Doc for Candidates. Additionally, be sure you register for the 2024 TRxA Funding Alternatives webinar at 10 a.m. ET, Tuesday, January 30. Content material will embrace an summary of the sorts of tasks TRxA funds, eligibility standards for TRxA awards, and particulars about how you can apply earlier than the primary submission deadline of March 31, 2024. The webinar will conclude with a stay Q&A.
To study extra, go to c-path.org/packages/trxa or electronic mail TRxA at [email protected].